Similar Search Results

La evalucación económica en España : el camino recorrido

Antoñanzas Villar, Fernando - In: Ekonomiaz (1993), pp. 58-69

Persistent link: https://www.econbiz.de/10001160147

La reforma del sistema sanitario

Antoñanzas Villar, Fernando (contributor); … - 1992

Persistent link: https://www.econbiz.de/10000856467

Costes directos e indirectos del cáncer en España

Antoñanzas Villar, Fernando; Oliva, Juan; Velasco, María - In: Información comercial española / Cuadernos económicos 72 (2006), pp. 281-309

Persistent link: https://www.econbiz.de/10003464193

Spanish recommendations on economic evaluation of health technologies

López-Bastida, Julio; Oliva, Juan; Antoñanzas Villar, … - In: The European journal of health economics : HEPAC ; … 11 (2010) 5, pp. 513-520

Persistent link: https://www.econbiz.de/10008662723

Economic aspects of the new Spanish laws on pharmaceutical preparations

Antoñanzas Villar, Fernando; Oliva, Juan; Pinillos … - In: The European journal of health economics : HEPAC ; … 8 (2007) 3, pp. 297-300

Persistent link: https://www.econbiz.de/10003546677

Feeding the economics of obesity in the EU in a healthy way

Antoñanzas Villar, Fernando; Rodríguez, Roberto - In: The European journal of health economics : HEPAC ; … 11 (2010) 4, pp. 351-353

Persistent link: https://www.econbiz.de/10003987307

Innovation, loyalty and generic competition in pharmaceutical markets

Antoñanzas Villar, Fernando; Juárez-Castelló, Carmelo; … - In: SERIEs : Journal of the Spanish Economic Association 2 (2011) 1, pp. 75-95

We analyze how a manufacturer with a brand-name drug close to patent expiration decides to launch a product-line extension (an upgrade through innovation) before it faces generic competition. There are two types of physicians: loyal physicians always prescribe first the product-line extension...

Persistent link: https://www.econbiz.de/10009355566

Should health authorities offer risk-sharing contracts to pharmaceutical firms? : a theoretical approach

Antoñanzas Villar, Fernando; Juarez-Castello, Carmelo; … - In: Health economics, policy and law 6 (2011) 3, pp. 391-403

Persistent link: https://www.econbiz.de/10009247147

Is personalized medicine a panacea for health management? : some thoughts on its desirability

Antoñanzas Villar, Fernando; Juárez-Castelló, Carmelo A. - In: The European journal of health economics : HEPAC ; … 16 (2015) 5, pp. 455-457

Persistent link: https://www.econbiz.de/10011299241

Genetic testing in the European Union : does economic evaluation matter?

Antoñanzas Villar, Fernando; Rodríguez-Ibeas, Roberto; … - In: The European journal of health economics : HEPAC ; … 13 (2012) 5, pp. 651-661

Persistent link: https://www.econbiz.de/10009658373